| Literature DB >> 27938367 |
Xhevat Lumi1, Zala Lužnik2, Goran Petrovski3,4, Beáta Éva Petrovski5,6, Marko Hawlina2.
Abstract
BACKGROUND: Pars plana vitrectomy (PPV) is preferred surgical procedure for the management of complex rhegmatogenous retinal detachment (RRD). The purpose of this study was to evaluate the anatomical results of primary PPV for the treatment of primary complex RRD and to determine the influence of lens status, tamponading agent, preoperative proliferative vitreoretinopathy (PVR) and axial length (AL) of the eye upon the anatomical outcome.Entities:
Keywords: Axial length; Pars plana vitrectomy; Proliferative vitreoretinopathy; Pseudophakia; Rhegmatogenous retinal detachment
Mesh:
Year: 2016 PMID: 27938367 PMCID: PMC5148843 DOI: 10.1186/s12886-016-0390-2
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Fig. 1Scatter plot of duration of symptoms (days) and age (years) in the two studied gender
General and ocular characteristics of patients included in the study. Descriptive statistics of numerical variables for both gender groups in relation to demographic profile
| Factors Studied | All patients ( | Gender (sex ratio = 1.9) |
| |
|---|---|---|---|---|
| Male ( | Female ( | |||
| BCVA preop (logMAR) (median, range) | 1.3 (0–3) | 1.0 (0–3) | 2.0 (0–3) | 0.25a |
| Lens status (n, %) | ||||
| Phakic | 59 (50.4%) | 33 (42.9%) | 26 (65.0%) | 0.032b* |
| Pseudophakic | 58 (49.6%) | 44 (57.1%) | 14 (35.0%) | |
| PVR status | ||||
| PVR < grade C1 (n, %) | 91 (77.8%) | 62 (80.8%) | 29 (72.5%) | 0.3b |
| PVR ≥ grade C1 (n, %) | 26 (22.2%) | 15 (19.5%) | 11 (27.5%) | |
| Reattachment rate (n, %) | 110/117 (94%) | 73/77 (94.8%) | 17/40 (92.5%) | 0.7b |
*p < 0.05 was considered statistically significant. aMann–Whitney U test; bChi-Square test
Effect of lens status (irrespective of the tamponade use) on the 12-month postsurgical retinal reattachment rate following PPV
| Lens status | Phakic ( | Pseudophakic ( |
|
|---|---|---|---|
| Reattachment rate (%) | 94.9% (56/59) | 93.1% (54/58) | 0.7 |
Comparison between the studied groups in relation to demographic profile, history of symptoms, visual acuity and PVR status
| Variables | Groups |
| |||
|---|---|---|---|---|---|
| G1 (Phakic + gas) ( | G2 (Pseudophakic + gas) ( | G3(Phakic + SO) ( | G4 (Pseudophakic + SO) ( | ||
| Male gender (n,%) | 25/46 (54.7%) | 32/43 (74.4%) | 8/13 (61.5%) | 12/15 (80.0%) | 0.14a |
| Age (mean ± SD) | 58.5 ± 13.5 | 62.7 ± 10.2 | 51.6 ± 17.8 | 70.7 ± 9.5 | 0.001c* |
| Duration of symptoms (days) | 7 (0–185) | 7 (1–256) | 7 (1–730) | 6 (0–230) | 0.9d |
| Preop BCVA (in logMAR) | 1.5 (0.05–3) | 0.52 (0–3) | 2 (0–3) | 3 (0.2–3) | 0.03d* |
| Preoperative PVR (n, %) | 11/46 (23.9%) | 4/43 (9.3%) | 5/13 (38.5%) | 6/15 (40.0%) | 0.03a* |
| Reattachment rate (n,%) | 100% (46/46) | 95.3% (41/43) | 76.9% (10/13) | 86.7% (13/15) | 0.011b* |
| Preoperative IOP | 14.8 ± 4.7 (0–26) | 14.2 ± 4.7 (5–24) | 14.7 ± 3.2 (10–21) | 10.9 ± 5.9 (0–21) | 0.064c |
| Postoperative IOP | 16.1 ± 4.0 (10–27) | 14.8 ± 3.2 (9–25) | 16.5 ± 7.0 (4–27) | 13.8 ± 3.3 (9–19) | 0.152c |
*p < 0.05 was considered statistically significant, aPearson Chi-Square; bFisher’s exact test, cANOVA test; dKruskal–Wallis test
Comparison between tested groups for anatomical outcome (redetachment rate)
| Groups | Anatomical outcome (Redetachment rate %) |
|---|---|
| G1 (Phakic + gas; | 0% vs 4.7%; ( |
| G3 (Phakic + SO; | 23.1% vs 13.3%; ( |
| G1 (Phakic + gas; | 0% vs 23.1%; ( |
| G2 (Pseudophakic + gas; | 4.7% vs 13.3%; ( |
| G1-G4 |
|
*p < 0.05 was considered statistically significant. Fisher’s exact test
Fig. 2Comparison between tested groups for anatomical outcome (redetachment rate). *p < 0.05 was considered statistically significant. Fisher’s exact test
Surgical details of the groups categorized according to the preoperative lens status and preoperative PVR status
| Variables | G5 (Phakic + no PVR) ( | G6 (Pseudophakic + no PVR) ( | G7 (Phakic + PVR) ( | G8 (Pseudophakic + PVR) ( |
|
|---|---|---|---|---|---|
| Reattachment rate (%, n) | 95.3% (41/43) | 93.7% (45/48) | 93.8% (15/16) | 90.0% (9/10) | 0.9b |
| Age (mean ± SD) | 55.4 ± 14.9 | 63.9 ± 11.0 | 61.3 ± 13.6 | 69.6 ± 6.5 | 0.002d* |
| Duration of symptoms (days) (median, range) | 5 (0–185) | 7 (1–256) | 14 (2–730) | 6.5 (0–230) | 0.075c |
| Male Gender (n, %) | 26/43 (60.5%) | 36/48 (75.0%) | 7/16 (43.8%) | 8/10 (80.0%) | 0.08a |
| Tamponade SO (n, %) | 8/43 (18.6%) | 9/48 (18.8%) | 5/16 (31.2%) | 6/10 (60.0%) | 0.08a |
| Preoperative IOP (mean ± SD, range) | 15.1 ± 4.5 (0–26) | 13.8 ± 5.1 (2–24) | 11.1 ± 4.0 (7–21) | 11.6 ± 5.4 (0–17) | 0.21d |
| Postoperative IOP (mean ± SD, range) | 16.9 ± 4.8* (4–27) | 14.5 ± 3.4* (9–25) | 14.1 ± 3.9* (6–22) | 14.8 ± 2.7 (11–18) | 0.02d* |
*p < 0.05 was considered statistically significant. aChi-Square, bFisher’s exact test; c Kruskal–Wallis test; dANOVA test
Comparison between groups in relation to the lens status and preoperative PVR on retinal redetachment rate
| Groups | Anatomical outcome |
|---|---|
| G5 (Phakic + no PVR) ( |
|
| G7 (Phakic + PVR) ( |
|
| G5 (Phakic + no PVR) ( |
|
| G6 (Pseudophakic + no PVR) ( |
|
| G5-G8 |
|
The effect of axial length on the redetachment rate
| No. of eyes | Total ( | Axial Length (mm) |
| |
|---|---|---|---|---|
| ≤24 mm ( | >24 mm ( | |||
| Redetachment (n,%) | 10/93 | 3/40 (7.5%) | 4/53 (7.5%) | 0.9 |